Eric Lefkofsky Brings Technology To Healthcare

Doctors were always aware that there was little information available on cancer. But somehow there was little that they could do about it. Even though there are cancer patients around the country, there was no comprehensive data available on it at one place. This was harming the doctors as they had no data for providing information in case they were looking at a treatment plan. In the end, it impacted the cancer patients the most.

Eric realized this once his wife was diagnosed with cancer. When he looked for more information regarding cancer diagnosis, he came across the absence of data and analysis with regard to cancer and its treatment.

This was when Lefkofsky came up with the idea of having an operating platform that can collate data on cancer patients across the country. This was how Tempus was founded. Next, he added on an analyzing service that could look at the treatment plans, the drugs being administered and the genetic makeup of the cancer patient. This allowed doctors to get access to a variety of treatment options.

Now if a doctor wanted to change a drug for a particular cancer patient, he could easily check out its impact on another patient with similar medical conditions and genetic makeup. This way the doctor will be prepared for the impact as well as after effects of that drug on the patient without even administering it. Lefkofsky at Facebook .

Eric Lefkofsky is highly excited with this venture. He is happy that he has been able to bring technology to the treatment of cancer. Ultimately it is all about combining technology with health care in order to benefit the patients.

Tempus is held and operated privately. This means that Eric Lefkofsky will not be answerable to any shareholders as it is not a public company.

For him, Tempus is personal business. He has been able to align each part of his family, business as well as philanthropy to Tempus. He finds a perfect symmetry here.

The fact is that 600,000 people are dying each year from cancer. The past 25 years have not seen much change in these figures. Eric Lefkofsky feels that having additional information can change treatment decisions.

http://www.lefkofsky.com/about for more .